Development of Kaposi’s sarcoma (case reports) with prolonged treatment with corticosteroids. Adverse systemic effects including Cushing’s syndrome, hyperglycemia, glycosuria, fluid and electrolyte changes, and reversible HPA axis suppression (particularly in younger children) may occur when used on large surface areas, for prolonged periods, or with an occlusive dressing. Chronic use of corticosteroids in children may interfere with growth and development. Infants and children may be more susceptible to adverse systemic effects. Children also are at greater risk of glucocorticoid insufficiency during and/or after withdrawal of treatment. Intracranial hypertension has occurred in children. For dermatologic use only. Occlusive dressings may be used for severe or resistant dermatoses. Avoid using occlusive dressings on weeping or exudative lesions, or in skin infection. Allergic contact dermatitis (may manifest as failure to heal). Irritation might occur. May cause atrophy of the epidermis and subcutaneous tissue, mostly in intertriginous (e.g. axilla, groin), flexor, and facial areas with prolonged use.